U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06950125) titled 'Evaluation of the JUICE HA(R) as an Anti-sarcopenia' on April 22.
Brief Summary: This study plans to recruit 60 participants aged 65 years and older who have been diagnosed with sarcopenia by a physician. Participants will be randomly assigned into JUICE HA(R) supplement and placebo group. All of the participants will be asked to take 15 mL/day of JUICE HA(R) supplement or placebo group for 12 weeks. The aim of this trial is to evaluate the potential of JUICE HA(R) to enhance physiological status (muscle mass and functional fitness) and to improve the quality of life in patients with sarcopenia.
Study Start Date: May 01
Study Type: ...